NBRV Annual Accounts Payable
$5.43 M
+$1.06 M+24.22%
31 December 2022
Summary:
As of January 28, 2025, NBRV annual accounts payable is $5.43 million, with the most recent change of +$1.06 million (+24.22%) on December 31, 2022. During the last 3 years, it has risen by +$758.00 thousand (+16.22%).NBRV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBRV Quarterly Accounts Payable
$6.98 M
+$1.55 M+28.48%
31 March 2023
Summary:
As of January 28, 2025, NBRV quarterly accounts payable is $6.98 million, with the most recent change of +$1.55 million (+28.48%) on March 31, 2023. Over the past year, it has increased by +$5.40 million (+342.21%).NBRV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBRV Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.2% | +342.2% |
| 3 y3 years | +16.2% | +243.2% |
| 5 y5 years | +5.7% | +83.3% |
NBRV Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -16.2% |
Nabriva Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $6.98 M(+28.5%) |
| Dec 2022 | $5.43 M(+24.2%) | $5.43 M(+39.4%) |
| Sept 2022 | - | $3.90 M(+263.0%) |
| June 2022 | - | $1.07 M(-32.0%) |
| Mar 2022 | - | $1.58 M(-63.9%) |
| Dec 2021 | $4.37 M(+51.3%) | $4.37 M(+196.2%) |
| Sept 2021 | - | $1.48 M(-6.7%) |
| June 2021 | - | $1.58 M(-56.5%) |
| Mar 2021 | - | $3.64 M(+25.9%) |
| Dec 2020 | $2.89 M(-38.2%) | $2.89 M(+41.5%) |
| Sept 2020 | - | $2.04 M(-22.1%) |
| June 2020 | - | $2.62 M(+28.9%) |
| Mar 2020 | - | $2.03 M(-56.5%) |
| Dec 2019 | $4.67 M(+41.4%) | $4.67 M(+45.1%) |
| Sept 2019 | - | $3.22 M(+10.5%) |
| June 2019 | - | $2.91 M(-61.5%) |
| Mar 2019 | - | $7.56 M(+128.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $3.30 M(-35.7%) | $3.30 M(-30.7%) |
| Sept 2018 | - | $4.76 M(+62.7%) |
| June 2018 | - | $2.93 M(-23.1%) |
| Mar 2018 | - | $3.81 M(-25.9%) |
| Dec 2017 | $5.14 M(+101.3%) | $5.14 M(-3.4%) |
| Sept 2017 | - | $5.32 M(-36.1%) |
| June 2017 | - | $8.32 M(+91.9%) |
| Mar 2017 | - | $4.34 M(+70.0%) |
| Dec 2016 | $2.55 M(-12.9%) | $2.55 M(-5.5%) |
| Sept 2016 | - | $2.70 M(+47.5%) |
| June 2016 | - | $1.83 M(-64.6%) |
| Mar 2016 | - | $5.16 M(+76.3%) |
| Dec 2015 | $2.93 M(+724.6%) | $2.93 M(+104.3%) |
| Sept 2015 | - | $1.43 M(+9.1%) |
| June 2015 | - | $1.31 M(-1.6%) |
| Mar 2015 | - | $1.34 M(+276.0%) |
| Dec 2014 | $355.10 K(-31.8%) | $355.10 K |
| Dec 2013 | $520.60 K | - |
FAQ
- What is Nabriva Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Nabriva Therapeutics?
- What is Nabriva Therapeutics annual accounts payable year-on-year change?
- What is Nabriva Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Nabriva Therapeutics?
- What is Nabriva Therapeutics quarterly accounts payable year-on-year change?
What is Nabriva Therapeutics annual accounts payable?
The current annual accounts payable of NBRV is $5.43 M
What is the all time high annual accounts payable for Nabriva Therapeutics?
Nabriva Therapeutics all-time high annual accounts payable is $5.43 M
What is Nabriva Therapeutics annual accounts payable year-on-year change?
Over the past year, NBRV annual accounts payable has changed by +$1.06 M (+24.22%)
What is Nabriva Therapeutics quarterly accounts payable?
The current quarterly accounts payable of NBRV is $6.98 M
What is the all time high quarterly accounts payable for Nabriva Therapeutics?
Nabriva Therapeutics all-time high quarterly accounts payable is $8.32 M
What is Nabriva Therapeutics quarterly accounts payable year-on-year change?
Over the past year, NBRV quarterly accounts payable has changed by +$5.40 M (+342.21%)